TY - JOUR
T1 - Peutz-Jeghers syndrome and cancer
T2 - A retrospective study in 14 Japanese patients with Peutz-Jeghers syndrome
AU - Iwamuro, Masaya
AU - Toyokawa, Tatsuya
AU - Moritou, Yuki
AU - Matsueda, Kazuhiro
AU - Hori, Shinichiro
AU - Yoshioka, Masao
AU - Tanaka, Takehiro
AU - Kawano, Seiji
AU - Okada, Hiroyuki
N1 - Publisher Copyright:
© 2019 Japanese Society of Gastroenterology. All rights reserved.
PY - 2019
Y1 - 2019
N2 - We retrospectively investigated 14 Japanese patients with Peutz-Jeghers (PJ) syndrome who were treated in six hospitals to determine the prevalence of cancer in Japanese patients with PJ syndrome. The study included seven males and seven females. The mean age at the time of diagnosis of PJ syndrome was 28.1 years (range 2-60 years). Hamartomatous polyps were observed in 13 (92.9%) patients, mucocutaneous pigmentation in 11 (78.6%), and positive family history in six patients (42.9%). The mean observation period after the diagnosis of PJ syndrome was 10.1 years (range 0-34 years). Although one patient died of cancer of unknown primary origin, the remaining 13 patients included in the study completed their last follow-up at each hospital. Cancers were detected in six patients (42.9%), including cancer of the uterine cervix (N=3), breast cancer (N=l), duodenal cancer (N=l), transverse colon cancer (N=l), and cancer of unknown primary origin (N=l). One patient presented with both cervical cancer and breast cancer. No patient presented with pancreatic cancer. This study highlights that patients with PJ syndrome are at high risk for intestinal and extra-intestinal cancers, such as uterine and breast cancer. Routine surveillance for intestinal and extraintestinal malignancies is warranted in patients with PJ syndrome.
AB - We retrospectively investigated 14 Japanese patients with Peutz-Jeghers (PJ) syndrome who were treated in six hospitals to determine the prevalence of cancer in Japanese patients with PJ syndrome. The study included seven males and seven females. The mean age at the time of diagnosis of PJ syndrome was 28.1 years (range 2-60 years). Hamartomatous polyps were observed in 13 (92.9%) patients, mucocutaneous pigmentation in 11 (78.6%), and positive family history in six patients (42.9%). The mean observation period after the diagnosis of PJ syndrome was 10.1 years (range 0-34 years). Although one patient died of cancer of unknown primary origin, the remaining 13 patients included in the study completed their last follow-up at each hospital. Cancers were detected in six patients (42.9%), including cancer of the uterine cervix (N=3), breast cancer (N=l), duodenal cancer (N=l), transverse colon cancer (N=l), and cancer of unknown primary origin (N=l). One patient presented with both cervical cancer and breast cancer. No patient presented with pancreatic cancer. This study highlights that patients with PJ syndrome are at high risk for intestinal and extra-intestinal cancers, such as uterine and breast cancer. Routine surveillance for intestinal and extraintestinal malignancies is warranted in patients with PJ syndrome.
UR - http://www.scopus.com/inward/record.url?scp=85076422377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076422377&partnerID=8YFLogxK
U2 - 10.11405/nisshoshi.116.1015
DO - 10.11405/nisshoshi.116.1015
M3 - Article
C2 - 31827041
AN - SCOPUS:85076422377
SN - 0446-6586
VL - 116
SP - 1015
EP - 1021
JO - Japanese Journal of Gastroenterology
JF - Japanese Journal of Gastroenterology
IS - 12
ER -